Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data.
Identifieur interne : 000371 ( Main/Exploration ); précédent : 000370; suivant : 000372Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data.
Auteurs : M A J B. Tacken [Pays-Bas] ; J C C. Braspenning ; A. Berende ; E. Hak ; D H De Bakker ; P P Groenewegen ; R P T M. GrolSource :
- Vaccine [ 0264-410X ] ; 2004.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Collecte de données (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Humains (MeSH), Modèles statistiques (MeSH), Mâle (MeSH), Odds ratio (MeSH), Pays-Bas (épidémiologie), Risque (MeSH), Soins de santé primaires (statistiques et données numériques), Sujet âgé (MeSH), Vaccins antigrippaux (usage thérapeutique), Épidémies de maladies (MeSH), Études de cohortes (MeSH), Études rétrospectives (MeSH).
- MESH :
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Soins de santé primaires.
- usage thérapeutique : Vaccins antigrippaux.
- épidémiologie : Grippe humaine, Pays-Bas.
- Adolescent, Adulte, Adulte d'âge moyen, Collecte de données, Femelle, Humains, Modèles statistiques, Mâle, Odds ratio, Risque, Sujet âgé, Épidémies de maladies, Études de cohortes, Études rétrospectives.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Cohort Studies (MeSH), Data Collection (MeSH), Disease Outbreaks (MeSH), Female (MeSH), Humans (MeSH), Influenza Vaccines (therapeutic use), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male (MeSH), Middle Aged (MeSH), Models, Statistical (MeSH), Netherlands (epidemiology), Odds Ratio (MeSH), Primary Health Care (statistics & numerical data), Retrospective Studies (MeSH), Risk (MeSH).
- MESH :
- chemical , therapeutic use : Influenza Vaccines.
- epidemiology : Influenza, Human, Netherlands.
- prevention & control : Influenza, Human.
- statistics & numerical data : Primary Health Care.
- Adolescent, Adult, Aged, Cohort Studies, Data Collection, Disease Outbreaks, Female, Humans, Male, Middle Aged, Models, Statistical, Odds Ratio, Retrospective Studies, Risk.
Abstract
A general practice (GP) based retrospective cohort study was conducted to assess the effects of influenza vaccination on the primary care contact rate during influenza epidemics. Given the rising workload of family physicians, particularly due to ageing of the population, it is very relevant to know to whether influenza vaccination of high-risk patients reduces the contact rate during epidemics. No effect of vaccination was found on the contact rate of GP during a mild epidemic period. During a 'normal' influenza epidemic, the workload was reduced through fewer contacts by patients with cardiovascular or diabetic diseases. Epidemic periods severe enough to show contact rate reduction occurred approximately every other year.
DOI: 10.1016/j.vaccine.2004.02.017
PubMed: 15297046
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data.</title><author><name sortKey="Tacken, M A J B" sort="Tacken, M A J B" uniqKey="Tacken M" first="M A J B" last="Tacken">M A J B. Tacken</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Quality of Care Research, University Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. m.tacken@wok.umcn.nl</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Centre for Quality of Care Research, University Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijmegen</wicri:regionArea><wicri:noRegion>6500 HB Nijmegen</wicri:noRegion></affiliation></author><author><name sortKey="Braspenning, J C C" sort="Braspenning, J C C" uniqKey="Braspenning J" first="J C C" last="Braspenning">J C C. Braspenning</name></author><author><name sortKey="Berende, A" sort="Berende, A" uniqKey="Berende A" first="A" last="Berende">A. Berende</name></author><author><name sortKey="Hak, E" sort="Hak, E" uniqKey="Hak E" first="E" last="Hak">E. Hak</name></author><author><name sortKey="De Bakker, D H" sort="De Bakker, D H" uniqKey="De Bakker D" first="D H" last="De Bakker">D H De Bakker</name></author><author><name sortKey="Groenewegen, P P" sort="Groenewegen, P P" uniqKey="Groenewegen P" first="P P" last="Groenewegen">P P Groenewegen</name></author><author><name sortKey="Grol, R P T M" sort="Grol, R P T M" uniqKey="Grol R" first="R P T M" last="Grol">R P T M. Grol</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15297046</idno><idno type="pmid">15297046</idno><idno type="doi">10.1016/j.vaccine.2004.02.017</idno><idno type="wicri:Area/Main/Corpus">000379</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000379</idno><idno type="wicri:Area/Main/Curation">000379</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000379</idno><idno type="wicri:Area/Main/Exploration">000379</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data.</title><author><name sortKey="Tacken, M A J B" sort="Tacken, M A J B" uniqKey="Tacken M" first="M A J B" last="Tacken">M A J B. Tacken</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Quality of Care Research, University Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. m.tacken@wok.umcn.nl</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Centre for Quality of Care Research, University Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijmegen</wicri:regionArea><wicri:noRegion>6500 HB Nijmegen</wicri:noRegion></affiliation></author><author><name sortKey="Braspenning, J C C" sort="Braspenning, J C C" uniqKey="Braspenning J" first="J C C" last="Braspenning">J C C. Braspenning</name></author><author><name sortKey="Berende, A" sort="Berende, A" uniqKey="Berende A" first="A" last="Berende">A. Berende</name></author><author><name sortKey="Hak, E" sort="Hak, E" uniqKey="Hak E" first="E" last="Hak">E. Hak</name></author><author><name sortKey="De Bakker, D H" sort="De Bakker, D H" uniqKey="De Bakker D" first="D H" last="De Bakker">D H De Bakker</name></author><author><name sortKey="Groenewegen, P P" sort="Groenewegen, P P" uniqKey="Groenewegen P" first="P P" last="Groenewegen">P P Groenewegen</name></author><author><name sortKey="Grol, R P T M" sort="Grol, R P T M" uniqKey="Grol R" first="R P T M" last="Grol">R P T M. Grol</name></author></analytic><series><title level="j">Vaccine</title><idno type="ISSN">0264-410X</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Cohort Studies (MeSH)</term><term>Data Collection (MeSH)</term><term>Disease Outbreaks (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Models, Statistical (MeSH)</term><term>Netherlands (epidemiology)</term><term>Odds Ratio (MeSH)</term><term>Primary Health Care (statistics & numerical data)</term><term>Retrospective Studies (MeSH)</term><term>Risk (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Collecte de données (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Modèles statistiques (MeSH)</term><term>Mâle (MeSH)</term><term>Odds ratio (MeSH)</term><term>Pays-Bas (épidémiologie)</term><term>Risque (MeSH)</term><term>Soins de santé primaires (statistiques et données numériques)</term><term>Sujet âgé (MeSH)</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>Épidémies de maladies (MeSH)</term><term>Études de cohortes (MeSH)</term><term>Études rétrospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term><term>Netherlands</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Primary Health Care</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Soins de santé primaires</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Pays-Bas</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Cohort Studies</term><term>Data Collection</term><term>Disease Outbreaks</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Models, Statistical</term><term>Odds Ratio</term><term>Retrospective Studies</term><term>Risk</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Collecte de données</term><term>Femelle</term><term>Humains</term><term>Modèles statistiques</term><term>Mâle</term><term>Odds ratio</term><term>Risque</term><term>Sujet âgé</term><term>Épidémies de maladies</term><term>Études de cohortes</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A general practice (GP) based retrospective cohort study was conducted to assess the effects of influenza vaccination on the primary care contact rate during influenza epidemics. Given the rising workload of family physicians, particularly due to ageing of the population, it is very relevant to know to whether influenza vaccination of high-risk patients reduces the contact rate during epidemics. No effect of vaccination was found on the contact rate of GP during a mild epidemic period. During a 'normal' influenza epidemic, the workload was reduced through fewer contacts by patients with cardiovascular or diabetic diseases. Epidemic periods severe enough to show contact rate reduction occurred approximately every other year.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15297046</PMID><DateCompleted><Year>2004</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0264-410X</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>23-24</Issue><PubDate><Year>2004</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data.</ArticleTitle><Pagination><MedlinePgn>2985-92</MedlinePgn></Pagination><Abstract><AbstractText>A general practice (GP) based retrospective cohort study was conducted to assess the effects of influenza vaccination on the primary care contact rate during influenza epidemics. Given the rising workload of family physicians, particularly due to ageing of the population, it is very relevant to know to whether influenza vaccination of high-risk patients reduces the contact rate during epidemics. No effect of vaccination was found on the contact rate of GP during a mild epidemic period. During a 'normal' influenza epidemic, the workload was reduced through fewer contacts by patients with cardiovascular or diabetic diseases. Epidemic periods severe enough to show contact rate reduction occurred approximately every other year.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tacken</LastName><ForeName>M A J B</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centre for Quality of Care Research, University Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. m.tacken@wok.umcn.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braspenning</LastName><ForeName>J C C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Berende</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hak</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>De Bakker</LastName><ForeName>D H</ForeName><Initials>DH</Initials></Author><Author ValidYN="Y"><LastName>Groenewegen</LastName><ForeName>P P</ForeName><Initials>PP</Initials></Author><Author ValidYN="Y"><LastName>Grol</LastName><ForeName>R P T M</ForeName><Initials>RP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2003</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>02</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>8</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>11</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>8</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15297046</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2004.02.017</ArticleId><ArticleId IdType="pii">S0264410X04001756</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country></list><tree><noCountry><name sortKey="Berende, A" sort="Berende, A" uniqKey="Berende A" first="A" last="Berende">A. Berende</name><name sortKey="Braspenning, J C C" sort="Braspenning, J C C" uniqKey="Braspenning J" first="J C C" last="Braspenning">J C C. Braspenning</name><name sortKey="De Bakker, D H" sort="De Bakker, D H" uniqKey="De Bakker D" first="D H" last="De Bakker">D H De Bakker</name><name sortKey="Groenewegen, P P" sort="Groenewegen, P P" uniqKey="Groenewegen P" first="P P" last="Groenewegen">P P Groenewegen</name><name sortKey="Grol, R P T M" sort="Grol, R P T M" uniqKey="Grol R" first="R P T M" last="Grol">R P T M. Grol</name><name sortKey="Hak, E" sort="Hak, E" uniqKey="Hak E" first="E" last="Hak">E. Hak</name></noCountry><country name="Pays-Bas"><noRegion><name sortKey="Tacken, M A J B" sort="Tacken, M A J B" uniqKey="Tacken M" first="M A J B" last="Tacken">M A J B. Tacken</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000371 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000371 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippePaysBasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15297046
|texte= Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15297046" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippePaysBasV1
| This area was generated with Dilib version V0.6.35. |  |